• Accelero_Spring_2017_1.jpg
  • Accelero_Spring_2017_2.jpg
  • Accelero_Spring_2017_3.jpg
  • Accelero_Spring_2017_4.jpg
  • Accelero_Spring_2017_5.jpg
  • Accelero_Spring_2017_6.jpg
  • Accelero_Spring_2017_7.jpg
  • Accelero_Spring_2017_8.jpg
  • Accelero_Spring_2017_9.jpg

 

Berlin, 21 October 2019

Accelero Bioanalytics GmbH (“Accelero”) signed an agreement with the gene therapy company CombiGene AB, Lund, Sweden (“CombiGene”) to support the non-clinical development of an Adeno-associated virus (AAV) with its bioanalytical and regulatory expertise.

 

Berlin, 27 September 2019

Accelero is pleased to announce that the company has been selected as a sustaining member of the CONELIS network life science. The CONELIS network accumulates top-class consulting services for the biotechnology and pharmaceutical industry.

 

Berlin, 04 June 2019

Accelero is pleased to announce that the company participates as a partner organization in the Marie Curie TRAIN-HEART consortium funded by the European Commission.

Accelero Bioanalytics GmbH, a Berlin-based GLP certified bioanalytical service provider, announces today that the GLP certificate first issued in 2016 has now been renewed by the competent authority for another three years. The re-inspection has been conducted in November 2018.